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DevelopmentWe recently identiﬁed a class of neuronal gene inheriting high levels of intragenic methylation from the mother
andmaintaining this through later development.We showhere that these genes are implicated in basic neuronal
functions such as post-synaptic signalling, rather than neuronal development and inherit high levels of 5mC, but
not 5hmC, from the mother. 5mC is distributed across the gene body and appears to facilitate transcription, as
transcription is reduced in DNA methyltransferase I (Dnmt1) knockout embryonic stem cells as well as in ﬁbro-
blasts treatedwith amethyltransferase inhibitor. However in adult brain, transcription ismore closely associated
with a gain in 5hmC, which occurs without a measurable loss of 5mC. These ﬁndings add to growing evidence
that there may be a role for 5mC in promoting transcription as well as its classical role in gene silencing.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
DNA methylation in mammals usually refers to the modiﬁcation of
cytosine by the addition of amethyl group to the 5′ position (5mC), usu-
ally at the CpG dinucleotide. However, study of the Ten-Eleven Translo-
cation (TET) proteins and advances in sequencing approaches have
revealed that TETs can convert 5mC to 5-hydroxymethylcytosine
(5hmC), which is widely found in brain and other CNS components
(see review articles by the Tang and Pfeifer labs, this issue). TETs can ca-
talyse the formation of the further derivatives 5-formylcytosine (5fC)
and 5-carboxylcytosine (5caC), which appear to be turned over more
rapidly, at which point the modiﬁed base possibly is removed from
the DNA by the base excision repair enzyme Thymidine DNA
Glycosylase (TDG) [1–3].
5hmC and further products can only be formed from 5mC, as in the
absence of this base none of the former bases are found [4], suggesting
that TET-mediated oxidation is the main pathway for active demethyl-
ation in mammals. Consistent with this, loss of TET3 prevents the de-
methylation of DNA in the paternal pronucleus post-fertilisation [5].
In contrast, the relatively steady levels of 5hmC in neural tissues,
whichhave very low turnover rates, suggest that itmay be playing a dif-
ferent role there. A number of studies have found 5hmC to be enriched
in gene bodies in neural precursor cells (NPC), and to be positively cor-
related with transcription [6–8]. Loss of TET1 compromised the self-
renewal capacity of NPC and led to decreased transcription of a numberof genes involved in progenitor proliferation [6]. Likewise, it has recent-
ly been shown that loss of intragenic 5mC led to a decrease, rather than
an increase, in transcription levels in embryonic stem cells (ESC) lacking
DNMT3L [9], suggesting that this type of methylationmay be needed to
achieve high levels of transcription. Another study has also shown that
transcription of a class of brain-speciﬁc genes most highly expressed in
NPC was diminished in the absence of the de novo enzyme DNMT3A
[10].
Roles for DNA methylation in promoting transcription are in sharp
contrast to its “classical” role in repressing transcription when found
at promoter CpG islands (CGI). CGI have been identiﬁed by bioinformat-
ic means but more recently, biochemical assays based on binding of the
CXXCdomain protein CFP1 (CXXC1) have been used to identify CGI con-
served between mouse and human, almost half of which were not de-
tected bioinformatically [11,12]. Many CFP1-deﬁned CGI are located
away from annotated promoters in intra- or intergenic locations, so-
called “orphan” CGI [13].
We recently identiﬁed a class of neuronal gene based on their meth-
ylation ontogeny (16). These genes appeared to become methylated at
speciﬁc intragenic CGI in the oocyte, then retain this methylation
through later development (Fig. 1A). Methylation was signiﬁcantly
lower or absent in sperm, then the remaining methylation was essen-
tially lost by the blastocyst stage: following implantation, the paternal
allele became de novomethylated leading to almost complete methyla-
tion of both alleles in adult tissues. These genes thus resembled
imprinted gene ICR in their early methylation ontogeny, but differed
from them in their inability to retain a methylation-free paternal allele
post-implantation (Fig. 1A).
Fig. 1. Intragenicmethylation is established in the oocyte for a novel class of brain-speciﬁc gene. (A)Many genes only becomemethylated in the post-implantationwave of de novometh-
ylation (red). Some brain-speciﬁc genes have gametic differentially methylated regions (gDMR), inheriting high levels of methylation from oocytes, and are in this way comparable to
imprinted genes. Unlike imprinted genes, brain genes are not protected from methylation post-implantation. % meC (5mC + 5hmC) represents total % methylated cytosine, as a sum
of 5mC and 5hmC detected by pyrosequencing. (B) Analysis of the brain gDMR genes by DAVID indicates enrichment for general neuronal functions rather than neurodevelopmental
terms. P value, Bonferroni-corrected P value and false discovery rate (FDR) are indicated. (C) Structure and methylation at two representative brain genes with multiple CGI, numbered
from1 (promoter) to 4 (3′). Combining data from reduced representation bisulﬁte sequencing (RRBS) inmeiosis II (MII) oocytes [17]withwhole bisulﬁtomeampliﬁedDNA sequencing on
germinal vesicle (GV) oocytes [18] indicates methylation is not targeted to any one internal CGI. Promoter CGI are generally unmethylated (CGI1). (D) Many of the brain genes carrying
gDMR from oocytewere independently identiﬁed as having intragenic 5-hydroxymethylation (5hmC) in either neurons or neuronal precursor cells (NPC) or both [7]. (E) Structure of the
four brain loci studied inmore detail, indicating the positions of the CFP1-identiﬁed CGI (black, top line), classical CGI (green, second line) and probes used for combined 5mC/5hmC anal-
ysis by bisulﬁte pyrosequencing (pyro) and for 5hmC-speciﬁc assays (gluQPCR).
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class and their methylation. In particular, we wished to 1) determine if
there were any common features with respect to the function of these
genes, 2) determinewhethermethylationwas conﬁned solely to one in-
tragenic CGI, 3) determine what fraction, if any, of the cytosines
appearing in bisulﬁte-converted samples are in fact 5hmC rather than
5mC, 4) determine in more detail when and where methylation of the
paternal allele occurs post-implantation and 5) determine if there was
any functional requirement for the methylation by removing it and ex-
amining transcriptional response.
We show here that this neuronal gene class showing high levels of
intragenic methylation inherited from the mother are implicated inbasic neuronal functions such as post-synaptic signalling, rather than
developmental processes. These genes inherit high levels of 5mC, but
not 5hmC, largely from the mother, which may facilitate a poised tran-
scriptional state in ESC and cells of the blastocyst inner cell mass (ICM).
De novo methylation during differentiation further primes them for
high-level transcription, but this is only realised in neuronal tissues,
where appropriate transcription factors can be found, and is associated
with high levels of 5hmC. In contrast, methylation in non-neuronal tis-
sues consists almost exclusively of 5mC. Using pharmacological as well
as genetic approaches we demonstrate that while 5mC alone is insufﬁ-
cient to allow high-level transcription, its loss causes reproducible de-
creases in transcription levels in all tissues examined.
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2.1. Bioinformatic analysis of methylation state of a novel class of neuronal
genes
To determine what common features the novel neuronal gene class
might have, we looked for common ontologies among the genes using
the Functional Annotation and KEGG tools in DAVID [14,15]. The
former identiﬁed signiﬁcant enrichment of terms related to synapse
(P = 1.08 × 10−9), post-synaptic membrane (P = 7.65 × 10−6) and
dendrite (P = 2.19 × 10−5) among others (Fig. 1B), while the latter
highlighted, at lower signiﬁcance (both P N 1 × 10−4) gap junction
and axon guidance terms as over-represented in the group.
Our previous analyses had indicated that CGI being ﬂagged as
methylated by genome-wide analyses in oocyte were all intragenic,
often at a speciﬁc CGI, while the promoter CGI for these genes,
when present, were unmethylated in this cell type [16]. Combining
data from two extant studies [17,18] and examining genes with
multiple intragenic CGI conﬁrms that promoter CGI appear to be
unmethylated, but suggests that all intragenic CGI, and most likely
the entire body of the gene, are methylated: two examples Crocc
and Syt2 are shown (Fig. 1C). However signiﬁcant differences be-
tween the studies in terms of results for individual CGI underline
the need for gene-speciﬁc assays to conﬁrm which pattern is correct
at loci showing discrepancies. Notably, both of the studies employed
bisulﬁte-treatment followed by sequencing, which cannot distin-
guish between 5mC and 5hmC. This is signiﬁcant since half of the
genes in our group are ﬂagged as having intragenic, but not promot-
er, 5hmC enrichment in brain in a recent study [7] (99/199 in areas of
overlap—Fig. 1D). Notably a large fraction of these are already
enriched in 5hmC in neural precursor cells (NPC) (65/99—Fig. 1D),
suggesting that hydroxylation may be occurring earlier in develop-
ment, or potentially even be inherited from the gametes. To further
explore these questions we designed a set of assays to investigate
the levels of 5mC and 5hmC at representative genes from our neuro-
nal gene set (Fig. 1E).Fig. 2. Intragenic gametic methylation exists in the form of 5mC, not 5hmC, for the identi-
ﬁed brain genes. (A) Methylation is enriched at intragenic CGI in MII oocytes, with the
promoter CGI remaining unmethylated. (B) Increased methylation at intragenic CGI
in comparison with promoter CGI in sperm. (C) The level of 5hmC in oocytes is ubiq-
uitously low for the gene classes analysed, in comparison with the brain (+ve ctrl:
positive control). (D) Sperm is also largely devoid of 5hmC in the gene classes
examined.2.2. High levels of 5mC but not 5hmC in the neuronal gene set in gametes
We ﬁrst conﬁrmed that methylation in the oocyte was conﬁned
to the intragenic CGI: examination of the total methylation levels
(5mC + 5hmC) by bisulﬁte treatment followed by pyrosequencing
indicated that methylation was below 25% at promoter CGI (Fig. 2A),
as indicated in the genome-wide assays. We could also conﬁrm high
(N50%) methylation at the intragenic CGI examined (Fig. 2A), although
there was more variability here. On the whole pyrosequencing results
correlated well with genome-wide assays, although the average
methylation level of the 8 CpG in CGI2 of Crocc was substantially
lower using the former technique. While intragenic CGI show signif-
icantly higher methylation levels generally in oocyte than sperm as
we previously reported, the downstream CGI are also more methyl-
ated than the promoter in sperm (Fig. 2B).
To determine how much, if any, of the methylation detected using
bisulﬁte-dependent techniques is actually 5hmC and not 5mC, we
used Glu-qPCR, which takes advantage of the fact that the former
base alone can be glucosylated [19]. Using this we could detect rela-
tively low levels of 5hmC in oocytes, ranging from 1.3% (Crocc) to
~3.6% (Grin3b) (Fig. 2C). In contrast, levels of 5hmC at Grin3b in
brain using this assay were ~30% (Fig. 2C—positive control).
Hydroxymethylation levels at other gene classes (imprinted, testis-
speciﬁc) which show oocyte-speciﬁc methylation were slightly
higher (Fig. 2C), but all were b10% and differences were not statisti-
cally signiﬁcant. Likewise, 5hmC levels in sperm were generally very
low, with Grin3b being the highest at 8.5% (Fig. 2D), but all other
genes being uniformly lower than 2%.2.3. High but variable methylation levels in adult tissues
Comparison of methylation levels by pyrosequencing in oocyte, ESC
(which model the ICM of blastocyst) and soma conﬁrmed our previous
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implantation development, presumably through de novo methylation
of the paternal allele (Fig. 3A). In contrast, the ICR at Peg1 (Mest) re-
mains unmethylated (Fig. 3A), as expected of an imprinted gene. Previ-
ous analysis of a small number of adult mouse tissues [16] had
suggested that methylation was uniformly high for the brain genes.
However, extension of this analysis to additional tissues (Fig. 3B)
showed considerable variability existed, with methylation levels as
low as 25–35% in intestine (Adcy6) and ovary (Crocc).Fig. 3. Variability in total methylation levels between post-implantation tissues does not correla
fromMII oocyte, J1 (WT) ESC and soma (average of all adult tissues) indicatesmaternal inherita
post-implantation via de novo methylation of the paternal allele. Only Peg1 retains this parent
levels in individual adult tissues show variability. (C) Fold expression levels, relative to adult bra
to 10 (D) Absolute cytosine modiﬁcation levels (C, mC, hmC) at individual CpG sites measured
brain is enriched for 5hmC in comparison with heart (4/4 genes), with no signiﬁcant differencWe considered that the low levels of methylation as observed in
some adult tissues may reﬂect loss of methylation in expressing tissues
and that the brain gene groupmight havemembers that aremorewide-
ly transcribed than just in neural tissues. To examine this we carried out
RT-qPCR in different adult tissues: our results (Fig. 3C) indicated that
the majority of the brain genes examined were highly speciﬁc to brain
tissue, with the exception of Adcy6 which shows transcription levels
in non-neural tissues of almost 50% the level seen in brain (Fig. 3C). In
adult tissue there was no clear correlation between levels of total DNAte with expression for brain genes examined. (A)Methylation proﬁle during development
nce ofmethylation at the brain genes examined, which is retained in the ESC and then lost
-of-origin mark, and thus is protected from methylation in the soma. (B) The methylation
in, highlight predominant transcription in the adult brain. Levels in brainwere normalised
via Glu-qPCR in brain and heart tissues. Although similar total methylation levels exist, the
e in 5mC (3/4).
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and transcription levels, as a number of non-expressing tissues had little
5mC+ 5hmC (e.g. Crocc in ovary, Fig. 3C) while other tissues with high
mRNA levels had high methylation (e.g. Grin3b in brain).
Variation in the proportions of 5hmC to 5mC is one possible ex-
planation for the lack of correlation between transcription and total
methylation levels when using bisulﬁte-based techniques. In order
to distinguish 5hmC and 5mC but measure them in the same assay,
we used a second type of Glu-qPCR which can quantitate the relative
levels of unmodiﬁed cytosine as well as 5mC and 5hmC. Examination
of brain, where the target genes are transcribed at high levels
(Fig. 3D), showed that as much as 40% of the methylation at individual
CpG sites assayed was 5hmC rather than 5mC (Fig. 3D). In contrast,
other tissues such as heart showed levels of 5hmC which were signiﬁ-
cantly, or very signiﬁcantly, lower than in brain (Fig. 3D). On the other
hand, levels of 5mC showed no signiﬁcant difference between brain
and heart at 3/4 loci, indicating that adult brain is distinguished not
by a decrease in 5mC, but by an increase in 5hmC (Fig. 3D).
2.4. De novo methylation occurs early during differentiation and correlates
with increased transcription of the brain gene group
To determine if de novo methylation is occurring during the early
stages of differentiation or whether it may be occurring later in a
more tissue-speciﬁc fashion, we took advantage of a previously-
described in vitro differentiation system [20]. In this system ESC
were differentiated initially into primary embryoid bodies, which re-
semble the blastocyst, then into secondary embryoid bodies which
contain populations of neural precursor cells (NPC) [21] before
being specialised into haematopoietic stem cells (Fig. 4A). As controls,
we conﬁrmed that in this system the imprinted gene Peg1 remains sta-
ble in the 40–60% range seen in normal tissues [22], as expected of an
imprinted gene (Fig. 4B), while the germline-speciﬁc gene Sycp3 un-
dergoes de novo methylation from 25% to N80%, as seen in vivo [16].
The brain gene group were also found to undergo de novo methylation
as seen in vivo (Figs. 3A,B) leading to N75%methylation atGrin3b, Adcy6
and Crocc and a gain in methylation of N30% at all four loci examined.
These results were conﬁrmed using combined bisulﬁte modiﬁcation
and restriction analysis (COBRA) (data not shown).
As expected from in vivo studies and our previous characterisation
of this system, transcription of the germline gene Sycp3 decreased
signiﬁcantly as methylation at the promoter CGI increased during
differentiation (Fig. 4C). In contrast methylation at the intragenic
CGI of the brain genes correlated instead with increasing transcription
levels during the initial stages (Fig. 4C), before transcription drops in
the more specialised HSC (most likely due to the lack of required tran-
scription factors). This trend was especially clear for Adcy6 (Fig. 4D).
Transcription of all the brain genes was highest in secondary embryoid
body, which contains the most NPC. Likewise, there was a trend to
higher transcription levels in foetal brain over adult (Fig. 4E), although
this was not statistically signiﬁcant except for Adcy6. Examination of
5hmC and 5mC levels (Fig. 4F) showed that 1) combined methylation
(5hmC + 5mC) levels increased from foetal to adult brain; 2) 5mC
levels were higher in foetal brain and 3) in adult a greater fraction of
the total methylation consisted of 5hmC.
2.5. Depleting 5mC results in decreased transcription of the brain gene
group
The correlation between 5mC levels and transcription suggested
that this modiﬁcation may somehow facilitate transcription across the
brain genes. To test this, we ﬁrst examined ESC deﬁcient in the mainte-
nance DNA methyltransferase enzyme DNMT1. This conﬁrmed that
when methylation was signiﬁcantly reduced (Fig. 5A) mRNA levels
showed reproducible decreases for all four brain genes examined
(Fig. 5B). This is in contrast to a control imprinted gene which isunaffected (Fig. 5B) and to testis genes with methylated promoter CGI,
whichwe have previously shown to be upregulated [16]. A similar effect
was seen in Dnmt3a −/−Dnmt3b −/− double mutant ESC, though to a
lesser extent as expected from their higher residual methylation level
(data not shown). To conﬁrm and extend this, we examined the effects
of the pan-methyltransferase inhibitor 5′-aza-2′deoxyctidine (Aza) in
adult ﬁbroblasts. While the drug was less effective at reducing methyl-
ation, levels did decrease signiﬁcantly at many loci (Fig. 5C). Treatment
resulted in small but signiﬁcant and reproducible decreases in transcrip-
tion for 3/4 brain genes (Fig. 5D). In contrast, Aza treatment resulted in
derepression of Sycp3, normally repressed bymethylation of its promot-
er CGI post-implantation (Fig. 5D).
2.6. Conservation of methylation type and location at brain homologs in
humans
An important consideration in terms of determining functionality is
the degree of conservation between different species. Many of the neu-
ronal genes described above have human homologs: examination of
these loci showed that intragenic CGI were also often conserved. Data
from the UCSF brain DNA methylation study [12] typically shows con-
servation of 5mC distribution as well, with an unmethylated promoter
CGI but methylated intragenic CGI and gene body, as typiﬁed by
ADCY6 (Fig. 6A).We extended these observations to primary ﬁbroblasts
by generating genome-widemethylation data using the 450k beadarray
system: this data conﬁrms that upstream promoter CGI for the brain
genes tend to be unmethylated (PCS—Fig. 6A, bar graph), while down-
stream CGI in the gene body tend to be heavily methylated. Recent
work by Pfeifer et al. compared 5mC and 5hmC frequency genome-
wide using DNA immunoprecipitation-based techniques (DIP) [23]. Of
53 human homologs of our mouse genes that appeared in that dataset,
18/53 showed high levels of both 5mC and 5hmC intragenically from
their data: this fraction rose to 26/53 (49%) when combined with data
on 5mC distribution from the UCSF project and our own 450K dataset.
Since the DIP datasets have limited coverage compared to
resequencing-based approaches, this suggests that, conservatively, at
least half of all brain genes showing high levels of intragenic 5mC are
also enriched for intragenic 5hmC, as in mouse. In contrast, testis
genes showed low levels of intragenic 5hmC and 5mC, were transcrip-
tionally silent in brain and had high 5mC but little 5hmC at their pro-
moters [16,23] (also UCSF and 450K, data not shown).
To examine whether intragenic 5mC may play a similar role in
human at these loci, we used the hTERT-immortalised normal
human ﬁbroblast cell line hTERT-1604, which we have previously
found to have a similar methylation proﬁle to primary cells using
locus-speciﬁc approaches [24]. Initial observations from 450 K anal-
yses of independent samples suggest that these cells do indeed have
a similar proﬁle to primary ﬁbroblasts at themajority of CpGs examined
(see for example data for ADCY6 in Fig. 6A bar graph). We conﬁrmed
intragenic methylation in these cells by pyrosequencing at a number
of loci (Fig. 6B, cells—Aza). As for most other cultured adult human
cell lines [25], levels of 5hmC were very low at all sites assayed
(data not shown). Treatment of these cells with Aza gave a small de-
crease in transcription at 2/3 brain genes examined, while the
imprinted gene SNRPN was unaffected (Fig. 6C). The conservation
of position, methylation status and effects on transcription of these
CGI in human further supports their important role in regulation of
these genes.
3. Discussion
The class of brain-speciﬁc genes described here were initially identi-
ﬁed by us based on their higher levels of methylation in oocyte than
sperm, their dependence on DNMT3L for methylation establishment
and the transient nature of the DMR, which is erased by de novo meth-
ylation of the paternal allele post-implantation [16]. In that study, we
Fig. 4.De novo methylation occurs early during differentiation and correlates with increased transcription of the brain genes. (A) Schematic of in vitro ESC differentiation exper-
iment, from undifferentiated ESC to primary embryoid body (1°EB), secondary embryoid body (2°EB) and haemopoietic stem cell (HSC). (B) Methylation of brain genes in-
creases progressively during in vitro differentiation. (C) Expression levels increase with ESC differentiation, peaking in 2°EB which contains many NPC, before declining in
HSC. Sycp3 is a control and shows the opposite pattern, as previously reported (D) Adcy6 is upregulated similarly to genes in (C) in 2°EB, relative to ESC. (E) Adcy6 and Efna2
are upregulated in foetal (~e15.5) brain relative to adult brain. (F) Absolute cytosine modiﬁcation levels (C, mC, hmC) at individual CpG sites determined via glu-qPCR indicate
signiﬁcantly higher hmC levels (3/4), but not mC levels (3/4), in adult brain.
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ond class differed in that 1) they were largely testis-speciﬁc in their
transcription rather than brain-speciﬁc; 2) methylation was present at
the promoter rather than intragenically and 3) methylation repressed
the genes. Here we further characterise the brain genes and show that
methylation for these genes encompasses the whole gene body, while
the promoter is generally methylation-free, and we provide evidence
that the methylation facilitates transcription of the gene rather thanrepression, since in bothmouse and human, decreasingmethylation re-
duces rather than increases levels of mRNA.
The recent discovery of 5hmC and the ﬁnding that bisulﬁte-
dependent methods do not distinguish 5mC from 5hmC led us to an-
alyse 5hmC levels at the brain genes. Our results indicate that 5hmC
levels are highest for the novel genes in the adult brain, while levels
in other adult tissues and in gametes aremuch lower, suggesting that
5hmC does not contribute a substantial proportion of the inherited
Fig. 5. Depletion of methylation correlates with reduced transcription of brain genes. (A) Intragenic methylation of brain genes decreases in Dnmt1-depleted ESCs (1KO). (B) Removal of
methylation results in down-regulation of brain genes in ESCs. (C) Methylation levels in adult mouse ﬁbroblasts (3T3) before (−) and after (+) Aza treatment. (D) Aza treatment causes
transcriptional repression of brain genes assayed relative to untreated (Untr.) controls. Sycp3 is a control and shows the opposite pattern, as expected.
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development. How this ﬁts with 5hmC being a transient product in
the active demethylation of 5mC is not yet clear, but our ﬁndings
are consistent with work by Pfeifer, Ecker et al. [8,23], who describe
high levels of 5hmC co-localised with high levels of 5mC in adult
brain, suggesting a relatively stable mark (see also review by Pfeifer
et al. in this issue).
The reason why genes involved in steady-state neuronal function
should have particularly high levels of intragenic 5mC in oocyte and
early embryo is not currently clear. Consistent with our ﬁndings de-
scribed here, recent papers by others [9,10] have also uncovered a pre-
viously unappreciated role for intragenic 5mC in promoting gene
transcription, since loss of DNMT3L in ESC, or DNMT3A in brain, led to
decreased mRNA levels for many genes normally transcribed in brain.
The genes identiﬁed in those studies do not overlap signiﬁcantly with
those described here. Consistent with this, neurodevelopmentally im-
portant genes were largely absent from our group, while featuring
strongly elsewhere. It is possible that a need for high-level transcription
of the genes we have identiﬁed in early neurulating embryos may ex-
plain the highmethylation levels of these genes in oocyte and early em-
bryo. Recently, evidence has been emerging that the presence of read-
through RNA, enabled by a more open chromatin structure, may lead
to transcriptionally-coupled DNA methylation (reviewed in [26]). In
support of this, the brain genes show leaky expression in both mouse
and human ﬁbroblasts, which facilitated measurement of down-
regulation. Intragenic 5mC and read-through transcription are not a de-
fault state, asmany other genes such as the testis genes show low intra-
genic methylation and have undetectable transcript levels in adult
tissues.
There may be a loss of 5hmC as well as 5mC in the Dnmt1 KOmouse
ESC, since the hydroxymethylated form appears to be derived solely
from the methylated form [4]. However, with the exception of ESC, cul-
tured cell lines contain little or no 5hmC [25], so the repression of tran-
scription of our novel gene class which we see in mouse and human
ﬁbroblast lines must be due to loss of 5mC. Whether the intragenic5hmC is absolutely required for the high-level transcription seen in
adult brain for this gene class is currently unclear. Due to the anatomical
complexity of the brain, increased 5hmC in adult brain overall may
mask decreases in speciﬁc structures, or vice versa. Further analyses
using tissue-speciﬁc knockouts of the TET enzymes in the future may
help to clarify the role of 5hmC at these genes.
4. Materials and methods
4.1. Genome-wide methylation analysis and bioinformatics
For mouse, bioinformatic analysis was performed on published
genome-widemethylation datasets [7,12,17,18,23] using publicly avail-
able tools. Gene ontology analysis, including statistical signiﬁcance, was
carried out using DAVID [14,15]. For human, DNAwas isolated from the
hTERT-immortilised lung ﬁbroblast (hTERT-1604) cell line using the
phenol:chloroform:isoamyl alcohol (25:24:1—pH 8, Sigma-Aldrich,
Dorset, UK) extraction method (below). DNA from the foreskin ﬁbro-
blast cell line (PCS) was a kind gift from Dr. Fulvio Gandolﬁ. Purity and
integrity of the DNA preparations were conﬁrmed by 1% agarose gel
electrophoresis and absorbance measurements at 260/280 and 260/
230, prior to quantiﬁcation using the Picogreen ﬂuorescent assay
(Invitrogen, Paisley, UK) as per as per manufacturer's instructions. In
total, 500 ng of high quality bisulﬁte converted (Zymo Research Corpo-
ration, California, USA) DNA was analysed on the Illumina 450 k
beadarray which was then imaged using an Illumina iScan (Cambridge
Genomic Services, Cambridge). Output data were ﬁltered for the pres-
ence of SNPs and other QC factors and remaining CpG beta-values
were converted to % methylation and plotted against genomic loci
using GALAXY software [27].
4.2. Statistical analysis
Experiments were carried out in triplicate, excepting the Glu-
qPCR for oocyte and sperm, which were carried out in duplicate.
Fig. 6. Evidence for conservation of brain gene structure, methylation proﬁle and response to demethylation in human. (A) Representative gene homolog in human showing conserved
location of the promoter and intragenic CGI. Tracks from the UCSF brainmethylation study [12] show evidence for an unmethylated promoter (MRE CpG signal) consistent with the pres-
ence of trimethylation of histone 3 lysine 4 (H3K4me3). In contrast, the intragenic CGI ismethylated (MeDIP tracks) and the gene itself is actively transcribed (RNA-seq track). Analysis of
genome-widemethylation in both primary (PCS) and two samples of hTERT1604 ﬁbroblasts (Wild type A and K:WTA andWTK) conﬁrmed low levels of methylation at the promoter CGI
and high levels throughout the gene in both cell types (bar graph: location of indicative CpG assayed is shown). (B) Methylation levels in hTERT1604 cells before (−) and after (+) Aza
treatment. (C) Aza treatment causes transcriptional repression of 2/3 brain homologs assayed relative to untreated (Untr.) controls. The imprinted SNRPN gene was unaffected.
390 R.E. Irwin et al. / Genomics 104 (2014) 383–392Each set of experiments included at least one biological repeat. Sta-
tistical analysis of results was carried out in PRISM, EXCEL or
GRAPHPAD; signiﬁcance values throughout were based on Student's
t-test, and error bars represent standard error of the mean (SEM) on
all graphs. Signiﬁcance values are in some cases abbreviated as
*p b 0.05; **p b 0.01; and ***p b 0.001.
4.3. Cell culture and treatments
hTERT-1604 and NIH 3T3 cells were cultured as detailed in Rutledge
and Thakur et al. (2014).The mESCs, comprising WT J1, Dnmt1 KO and
Dnmt3a/3b KO, were a kind gift from Dr. M. Okano (RIKEN Center for
Developmental Biology, Kobe, Japan). ESCs were cultured as previously
described [16]. Material from in vitro differentiated ESCs was a kind gift
from Dr. Helen Wheadon (Paul O'Gorman Leukaemia Research Centre,
Glasgow, UK). For pharmacological inhibition of DNMT1 during culture,1 × 105 hTERT-1604 or NIH 3T3 cells were treated with 5-aza-2′-
deoxycytidine (5′aza-dC; Sigma-Aldrich, Dorset, UK), at a ﬁnal concen-
tration of 1 μM, on 3 consecutive days.
4.4. Animal work
Tissues of interest derived from outbred TO mice (Harlan,
Huntingdon, UK). Oocyte and sperm collection was carried out as
previously described [28,29]. All animal work was carried out under
licensing from the UK Home Ofﬁce.
4.5. DNA extraction and bisulﬁte treatment
DNA extraction from oocytes and sperm was performed as previ-
ously described [28,29]. DNA was extracted from cell pellets and tis-
sues using the phenol:chloroform:isoamyl alcohol (25:24:1—pH8,
391R.E. Irwin et al. / Genomics 104 (2014) 383–392Sigma-Aldrich) extraction method, involving overnight rotation–
incubation at 55 °C in lysis buffer (50 mM Tris pH8, 0.1 M EDTA,
0.5% SDS, 0.2 mg/ml Proteinase K). Approximately 150–200 oocytes
or 500 ng of DNA was bisulﬁte converted using the EpiTect Bisulﬁte
Kit (Qiagen, Crawley, UK).
4.6. RNA extraction, cDNA synthesis and RT-qPCR
RNA was extracted using the RNeasy Kit (Qiagen) according to
the manufacturer's instructions. cDNA was synthesised from 250 to
500 ng of RNA, combined in reaction with 0.5 μg random primers
(Roche), 0.5 μM dNTPs, 40U RNaseOUT (Invitrogen), 1x Buffer RT
and 200 U RevertAid reverse transcriptase (both Fermentas), and
made up to a ﬁnal volume of 20 μl using RNase-free water (Qiagen).
Reaction conditions were: 25 °C for 10 min, 42 °C for 60 min and
70 °C for 10 min. cDNA was used immediately or stored at−80 °C.
RT-qPCR was carried out using the Lightcycler 480 II (Roche, West
Sussex, UK). Primers for RT-qPCR were manually designed to be under
200 bp in length for the region of interest (Supplementary Table 1).
Each reaction consisted of 1x SYBR Green I Master (Roche), 0.5 μM of
each primer and was made up to a 10 μl reaction using 1 μl cDNA and
nuclease-free water (Qiagen). Reactions were: 95 °C for 10 min, 50 cy-
cles of 95 °C for 10 s, 60 °C for 10 s and 72 °C for 10 s. Expression was
normalised to Actb and relative expression was analysed via the ΔΔCT
method.
4.7. Glu-qPCR—quantiﬁcation of 5hmC and 5mC
For germcells, absolute levels of 5hmC at speciﬁc CpG sites (MspI re-
striction sites—CCGG) were quantiﬁed using the EpiJET 5-hmC Analysis
Kit (Thermo Scientiﬁc) according to the manufacturer's instructions
using approximately 400 oocytes or 250 ng of intact DNA (sperm),
followed by RT-qPCR. For tissues, absolute levels of each DNA modi-
ﬁcation (C, mC and hmC) at speciﬁc DNA loci (HpaII/Msp1 restriction
sites—CCGG) were quantiﬁed using the EpiMark 5hmC and 5mC
Analysis Kit (New England Biolabs) according to the manufacturer's
instructions. Absolute levels of each modiﬁcation, spanning a single
CCGG site, were then calculated based on the Cq (threshold) values,
normalised to a mock digestion (containing no enzyme).
4.8. Bisulﬁte methylation analysis
Pyrosequencing was carried out as previously described [16] using
pre-designed assays (Qiagen), excepting the intragenic assays for
Adcy6, Crocc and Efna2 which were designed in-house using PyroMark
Assay Design Software 2.0 (Supplementary Table 1). Bisulﬁte-treated
DNA was PCR ampliﬁed in 1x Buffer, 0.4 μM dNTPs, 1 μM primers and
MgCl2 at an optimal concentration to the primer set and 0.01U Taq
DNA Polymerase (all Invitrogen).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2014.08.013.
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